Aug 01, 09:07
Only BuyersOnly Buyers in Marksans Pharma on NSE
64% of moneycontrol users recommend buying Marksans Pharma.
What's your call on Marksans Pharma today?
Read 21 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2756.40||-1.82||2939.80||2140.35||46,951.15|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Thomas Cook (India) Recommended on May 9th 2014
Recommended price 89.00 | Peak from reco 128.95 44.56%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Marksans Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,254.17 crore.The company has reported a consolidated sales of Rs 168.75 crore and a Net Profit of Rs 22.99 crore for the quarter ended Dec 2013.
The company management includes Mark Saldanha - Chairman & Managing Director, B S Desai - Whole Time Director, S R Buddharaju - Director, Ajay S Joshi - Director, Naresh Balwant Wadhwa - Ind.& Non Exe.Director.
It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.
Its Registered office is at 11th Floor, Lotus Business Park,,Off New Link Road, Mumbai,Maharashtra - 400053.
Their Registrars are Bigshare Services Pvt. Ltd.